Skip to content
Sign up today for access to the latest pediatric solutions!
Sign up today for access to the latest pediatric solutions!

IP License - Prognostic Gene Signature and Method for Diffuse Large B-Cell Lymphoma Prognosis and Treatment

IP Licensing
Availability: Available On Demand

For informational purposes only. Please contact seller directly for more details.

Share This:

Systems, treatment and prognostic methods, and kits for risk stratification and development of treatment options for diffuse large B-cell lymphoma patients. The systems, methods, and kits comprise determining, detecting, and evaluating gene expression values for a defined gene panel, or a subset thereof, detected in a biological sample from the patient and determining a risk score associated with the gene signature panel, which can be used to guide treatment of the patient.

Shipping Information

Free shipping on orders in the continental United States.
We are unable to ship outside of the United States at this time.

Returns

Please contact the seller directly for their return policy and to handle returns. Customer will be responsible for return shipping fees.